<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>c-Myc is instrumental in the progression of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> including <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 human <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="1" pm="."><plain>We tested fatty acids for their inhibitory effect on the DNA binding of c-Myc/Max dimeric proteins of human origin, prepared as recombinant proteins encompassing DNA binding (basic) and dimerization (HLHZip) domain, and found that those suppress proliferation and induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of DMSO-differentiated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells </plain></SENT>
<SENT sid="2" pm="."><plain>The analyzed IC50 values of <z:chebi fb="0" ids="28875">myristic acid</z:chebi>, <z:chebi fb="0" ids="28842">stearic acid</z:chebi>, <z:chebi fb="3" ids="28661">gamma-linolenic acid</z:chebi>, <z:chebi fb="0" ids="17351">linoleic acid</z:chebi>, <z:chebi fb="0" ids="25048,27432">linolenic acid</z:chebi> and <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> by EMSA were 97(+/-3), 2.2(+/-1.2), 55(+/-5), 32(+/-2), 62(+/-12), 22(+/-2)microM for DNA binding of recombinant c-Myc/Max, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>According to the results shown by XTT assay, their influence on proliferation was quite different from the rank order of IC50 </plain></SENT>
<SENT sid="4" pm="."><plain>Whereas the degree of influence of the <z:chebi fb="2" ids="27208">unsaturated fatty acids</z:chebi> on the proliferation of DMSO-differentiated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells was similar, the influence of <z:chebi fb="4" ids="26607">saturated fatty acids</z:chebi>, <z:chebi fb="0" ids="28842">stearic acid</z:chebi> in particular, was very weak at same concentrations </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we confirmed that these fatty acids have no influence on the expression of c-Myc in DMSO-differentiated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells </plain></SENT>
<SENT sid="6" pm="."><plain>Our experiments demonstrated that the inhibitors for the DNA binding of c-Myc/Max contribute to the downregulation of Myc-dependent proliferation and to the inducement of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and serve as an exploration of potent new inhibitors </plain></SENT>
</text></document>